Article Text

PDF
Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS)

Abstract

Background Benzodiazepine use is widespread in older people, although its benefit is uncertain.

Aim To investigate the long-term effect of benzodiazepine use upon dementia risk.

Methods A prospective cohort of men seen on five occasions over 22 years with full medication histories, repeat measures of cognitive function and a clinical diagnosis of dementia.

Results Of 1134 men with complete data, 103 (9.1%) had been taking benzodiazepines regularly at one or more phases. These men showed a marked increased incidence of dementia (OR=3.50, 95% CI 1.57 to 7.79, p=0.002), which persisted despite adjustment for psychological distress and other covariates. Men exposed in earlier phases showed a greater association than more recent exposure, counter to what one would expect if this was due to reverse causation, though we failed to demonstrate a dose–response effect with drug duration.

Conclusion The taking of benzodiazepines is associated with an increased risk of dementia.

  • Dementia
  • benzodiazepines
  • cognitive function
  • epidemiology
  • ageing
  • psychosocial factors
  • public health
View Full Text

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.